Previous close | 42.50 |
Open | 41.88 |
Bid | 41.98 x 100 |
Ask | 42.77 x 100 |
Day's range | 40.81 - 42.60 |
52-week range | 11.00 - 48.60 |
Volume | |
Avg. volume | 40,430 |
Market cap | 1.251B |
Beta (5Y monthly) | -1.53 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The consensus price target hints at a 41.1% upside potential for Belite Bio (BLTE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Key Insights Belite Bio's estimated fair value is US$88.87 based on 2 Stage Free Cash Flow to Equity Belite Bio is...